Nuveen Asset Management LLC Grows Holdings in Doximity, Inc. (NASDAQ:DOCS)

Nuveen Asset Management LLC lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 48.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 464,658 shares of the company's stock after buying an additional 150,734 shares during the quarter. Nuveen Asset Management LLC owned about 0.25% of Doximity worth $24,808,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. FMR LLC lifted its holdings in shares of Doximity by 37.6% in the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock worth $502,363,000 after purchasing an additional 2,571,580 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Doximity by 708.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock worth $80,641,000 after purchasing an additional 1,323,634 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Doximity by 525.1% in the 4th quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock worth $67,934,000 after purchasing an additional 1,068,849 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Doximity by 1,178.3% in the 4th quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after purchasing an additional 979,113 shares in the last quarter. Finally, Fundsmith LLP bought a new position in shares of Doximity in the 4th quarter worth $37,934,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Insiders Place Their Bets

In other news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares in the company, valued at $946,062.74. The trade was a 10.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now owns 357,165 shares in the company, valued at $20,440,552.95. This trade represents a 11.19% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by corporate insiders.

Doximity Stock Up 1.6%

DOCS traded up $0.82 on Tuesday, hitting $51.84. The company's stock had a trading volume of 785,219 shares, compared to its average volume of 2,093,671. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21. The firm has a market cap of $9.68 billion, a P/E ratio of 51.89, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The company's 50 day simple moving average is $56.12 and its 200-day simple moving average is $58.23.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.25 EPS. Equities analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on DOCS shares. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. JPMorgan Chase & Co. cut their target price on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday. Mizuho cut their target price on Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Finally, Morgan Stanley dropped their price objective on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $61.89.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.